Determinants of durable humoral and T cell immunity in myeloma patients following COVID-19 vaccination
Description
CONCLUSIONS: Negative T-spot results predict low Anti-S antibody levels (<50 IU/mL) following a second COVID-19 vaccination and a number of biomarkers predict T cell responses in myeloma patients.